Cronos Group Pays $110.4 Million for Option to Acquire 10.5% of Private MSO PharmaCann

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Positioned in Limited License States Across the Midwest and Northeast TORONTO and CHICAGO, June 14, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) […]